Prime Medicine (PRME) Other Non-Current Assets (2021 - 2026)

Prime Medicine has reported Other Non-Current Assets for 6 years, with the latest figure at $13.7 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets fell 2.64% year-over-year to $13.7 million; the trailing twelve-month figure through Mar 2026 stood at $13.7 million (down 2.64% YoY), and the FY2025 full-year result was $13.7 million, down 2.64% from the prior year.
• Other Non-Current Assets for Q1 2026 stood at $13.7 million, roughly flat from $13.7 million in the prior quarter.
• The five-year high for Other Non-Current Assets was $14.1 million in Q3 2024, with the low at $779000.0 in Q4 2023.
• Historically, Other Non-Current Assets has averaged $12.2 million across 5 years, with a median of $13.5 million in 2022.
• Annual changes were most pronounced in 2022 — Other Non-Current Assets sank 87.44% — and 2024, when it soared 1705.13%.
• Prime Medicine's Other Non-Current Assets stood at $1.6 million in 2022, then sank by 52.67% to $779000.0 in 2023, then soared by 1705.13% to $14.1 million in 2024, then fell by 2.64% to $13.7 million in 2025, then changed by 0.0% to $13.7 million in 2026.
• The last three Other Non-Current Assets figures came in at $13.7 million (Q1 2026), $13.7 million (Q4 2025), and $13.7 million (Q3 2025), per Business Quant data.